COVID Conference News Features immunology tuberculosis VKS Events global health eSymposia Infectious Diseases leadership Virtual Keystone Symposia Drug Discovery

New Frontiers in Tuberculosis Research Dr. Bruno Andrade

0

In this KSQA feature interview, Dr. Bruno Andrade, co-organizer of the upcoming eSymposia virtual meeting on “Tuberculosis: Science Aimed at Ending the Epidemic,” shares how new technologies and integrative approaches are enabling a deeper understanding of tuberculosis pathogenesis, resistance mechanisms and epidemiology. These new insights and tools are leading researchers to better diagnostics, treatments and public health strategies against TB, with the potential to finally end the TB epidemic.

In addition, Andrade explains how COVID has impacted the field, from the patient to a public health perspective. He describes how the TB research community is uniquely positioned with the knowledge and tools to help, and how they have come together to address this new pulmonary threat.

Finally, Dr. Andrade also discusses his new role as Chief Editor of the new “Frontiers in Tropical Diseases” journal, which launches on December 7, 2020. Drawing from his own research experience, Andrade helped to shape the scope of the new journal to take on a novel integrative research perspective. Only by incorporating multi-dimensional information from diverse fields can we overcome TB resistance to achieve eradication, and Andrade aims to encourage and highlight such transformative cross-disciplinary collaborations with this new journal, and at the eSymposia virtual meeting.

Watch the Full Interview Here

Find out more about the "Tuberculosis: Science Aimed at Ending the Epidemic" eSymposia & View it On Demand Here!

See All Upcoming eSymposia!

 

Keystone Symposia Logo for Tuberculosis preview blog
Shannon Weiman
Shannon Weiman earned her PhD in Biomedical Sciences from the University of California, San Diego, specializing in microbiology and immunology. Prior to joining the Keystone Symposia team, she worked as a freelance writer for leaders in academic, industry and government research, including Stanford University’s Biomedical Innovation Initiative, the University of Colorado’s Biofrontiers Program, UCSF, the FDA and the American Society for Microbiology.
Prev
Next

Related news